Institutional Ownership
Vyne Therapeutics Inc
CUSIP 92941V308COMVYNEQ1 2026
13D / 13G Filings
14
Schedule 13D/13G on record
Beneficial Filers
6
Distinct reporting persons
Largest Stake
10.0%
Max % of class reported
Institutional Holders
41
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
14 filings · latest Nov 14, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Nov 14, 2025 | Eventide Asset Management, LLC | 13G/A | — | — | SEC |
| 2 | Nov 14, 2025 | Cormorant Asset Management, LP | 13G/A | — | — | SEC |
| 3 | Nov 14, 2025 | Citadel Advisors LLC | 13G/A | — | 3.7K | SEC |
| 4 | Aug 14, 2025 | Eventide Asset Management, LLC | 13G/A | 10.0% | — | SEC |
| 5 | Aug 14, 2025 | Cormorant Asset Management, LP | 13G/A | 8.2% | 1.37M | SEC |
| 6 | May 19, 2025 | Cormorant Asset Management, LP | 13G/A | 10.0% | 1.85M | SEC |
| 7 | May 15, 2025 | Cormorant Asset Management, LP | 13G/A | — | — | SEC |
| 8 | May 15, 2025 | Citadel Advisors LLC | 13G/A | 7.2% | 1.10M | SEC |
| 9 | Nov 14, 2024 | Soleus Capital Master Fund, L.P. | 13G/A | — | — | SEC |
| 10 | Feb 14, 2024 | Citadel Advisors LLC | 13G/A | 8.5% | — | SEC |
4 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Vyne Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Nantahala Capital Management, LLC | 2.00M | $1.20M |
| 2 | Lynx1 Capital Management LP | 1.63M | $973.1K |
| 3 | Shay Capital LLC | 1.61M | $962.1K |
| 4 | Anson Funds Management LP | 1.24M | $742.8K |
| 5 | Adar1 Capital Management, LLC | 1.06M | $635.7K |
| 6 | T3 Companies, LLC | 945.0K | $564.6K |
| 7 | Braidwell LP | 916.1K | $547.4K |
| 8 | Citadel Advisors LLC | 514.4K | $307.4K |
| 9 | Kvp Capital Advisors, LP | 500.6K | $299.1K |
| 10 | Two Sigma Investments, LP | 426.4K | $254.8K |